Life Sciences Quarterly – Q1 2026 edition

We are pleased to announce the launch of our new Life Sciences Quarterly – Q1 2026 edition.

Q1 2026 has already seen several significant legal and regulatory developments in the life sciences sector, and this edition provides a comprehensive overview of the key updates from Norway and the EU during the first quarter of 2026, including:

• Regulatory updates from Norway affecting the pharmaceutical and medical device sectors
• Important EU developments, including new EMA/FDA joint guidance on the use of AI in medicines development
• Recent case law from both Norway and the EU

We hope you find this edition informative and useful. Please do not hesitate to reach out if you have any questions or would like to discuss any of the topics covered.